American Well Co. (NYSE:AMWL) Shares Sold by Barclays PLC

Barclays PLC lowered its position in American Well Co. (NYSE:AMWL) by 95.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,108 shares of the company’s stock after selling 140,251 shares during the quarter. Barclays PLC’s holdings in American Well were worth $67,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. HighTower Advisors LLC bought a new stake in American Well during the third quarter worth approximately $355,000. PDT Partners LLC bought a new stake in shares of American Well in the 3rd quarter worth $107,000. Walleye Capital LLC bought a new position in American Well during the third quarter valued at about $167,000. BNP Paribas Financial Markets acquired a new position in American Well during the third quarter worth about $95,000. Finally, Point72 DIFC Ltd raised its position in American Well by 1,418.5% in the second quarter. Point72 DIFC Ltd now owns 103,457 shares of the company’s stock worth $34,000 after acquiring an additional 96,644 shares in the last quarter. 56.05% of the stock is currently owned by institutional investors and hedge funds.

American Well Trading Up 0.3 %

Shares of AMWL stock opened at $11.00 on Friday. The stock’s fifty day simple moving average is $8.53 and its 200-day simple moving average is $8.81. The company has a market capitalization of $168.49 million, a price-to-earnings ratio of -0.75 and a beta of 1.11. American Well Co. has a 1-year low of $5.00 and a 1-year high of $29.00.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on AMWL. Morgan Stanley lowered their price objective on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Wells Fargo & Company upgraded American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 target price on the stock in a report on Monday, January 13th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research report on Thursday, October 31st.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.